江苏浩欧博生物医药股份有限公司 2025年第三季度报告

Core Viewpoint - The company, Jiangsu Haooubo Biopharmaceutical Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, with no significant omissions or misleading statements [2][3]. Financial Data Summary - The financial statements for the third quarter are unaudited, covering the period from the beginning to the end of the quarter [3][7]. - The report includes major accounting data and financial indicators, although specific figures are not detailed in the provided text [3]. - The company has confirmed that there were no significant changes in the financial indicators compared to the previous period [4][6]. Shareholder Information - The total number of ordinary shareholders and the situation of the top ten shareholders are disclosed, with a specific mention of the repurchase account holding 801,314 shares, accounting for 1.26% of the total share capital [4][5]. Other Important Information - There are no additional reminders or significant operational updates regarding the company's performance during the reporting period [6].